In an era where immune health is more critical than ever, the global rise in immune-related challenges has sparked widespread concern.

Lactic acid bacteria fermentation has a wide range of applications in the food field. The most common ones include yogurt, lactic acid bacteria drinks and cheese.

Wecare Probiotics is thrilled to announce that its innovative probiotic strain, Weizmannia coagulans BC99, has been selected as a finalist for the prestigious Ingredient of the Year: Sports Nutrition award at the 2025 NutraIngredients Awards.

WeCare specializes in providing a diverse range of probiotic strains and tailored solutions. Introducing our flagship product, WecLac Bacillus Coagulans BC99, we strive to enhance well-being through innovative probiotic formulations and applications.

With rising cases and a push for gentler solutions, Wecare Probiotics has stepped up, spotlighting Bifidobacterium animalis subsp. lactis BLa80—a natural probiotic derived from breast milk in Sichuan, China—as a promising answer to this pervasive issue.

At Wecare Probiotics Co., Ltd., a national high-tech enterprise specializing in probiotics and intestinal flora research, we are particularly excited about these findings. Our commitment to advancing human health through probiotic strains and application solutions aligns with the study's implications for improving gut microbiome diversity.